靶向黏膜愈合的强化治疗算法在老年克罗恩病患者中有效且安全:REACT2试验的事后分析
本研究为REACT2试验的事后分析,评估以黏膜愈合为目标的强化治疗算法在老年克罗恩病患者中的安全性和有效性。结果显示,24个月时老年与年轻患者治疗无差异,强化治疗在老年患者中有效且与阶梯治疗相比未增加风险。
要点
- 强化治疗在老年克罗恩病患者中有效且安全。
- 24个月时老年与年轻患者治疗无差异。
- 强化治疗与阶梯治疗相比未增加风险。
核心结论
- 在老年克罗恩病患者中,以黏膜愈合为目标的强化治疗算法有效且与阶梯治疗相比未增加风险。
研究设计与样本
- REACT2试验的事后分析,该试验将临床实践随机分为强化治疗算法组或阶梯治疗算法组,以确定患者年龄是否修饰治疗效果。
主要发现
- 24个月时,老年与年轻患者之间的治疗无差异。
临床怎么用
- 对于老年克罗恩病患者,可考虑采用以黏膜愈合为目标的强化治疗算法,其有效且未增加风险。
局限性
- 本研究为事后分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Safety and effectiveness of treating to target mucosal healing in older patients with Crohn's disease (CD) is unknown. METHODS: We analyzed CD-related complications by 24 months in the randomized evaluation of an algorithm for Crohn's treatment-study 2-2 trial that randomized practices to an enhanced-care or step-care algorithm to determine whether patient age modifies the effect of treatment. Data were analyzed using marginal Cox regression and modified Poisson regression. RESULTS: There was no difference in treatment between younger and older patients in at 24 months. DISCUSSION: Enhanced-care was effective and not associated with increased risk compared with step-care in older patients with CD.
引用
- Goodwin SW, Vuyyuru SK, Sedano R, et al. An Enhanced Treatment Algorithm Targeting Mucosal Healing Is Effective and Safe in Older Patients With Crohn's Disease: A Post Hoc Analysis of the REACT2 Trial. Am J Gastroenterol. 2026. PMID: 41930770. doi:10.14309/ajg.0000000000004015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。